Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD)
GAD
Efficacy of Massage and Light Touch Therapy for the Treatment of Generalized Anxiety Disorder
2 other identifiers
interventional
40
1 country
1
Brief Summary
There is an impressive and growing body of data suggesting that massage therapy is effective in decreasing some symptoms of pathological conditions as well as facilitating growth, reducing pain, increasing alertness, diminishing symptoms of depression and anxiety, and enhancing immune function. Preliminary studies suggest that massage therapy decreases symptoms of anxiety and depression, and lowers salivary cortisol levels in a wide array of childhood and adult neuropsychiatric disorders including post-traumatic stress disorder, attention-deficit-disorder hyperactivity, depression, bulimia and anorexia-nervosa. Generalized Anxiety Disorder (GAD) is characterized by the presence of a constellation of signs and symptoms for at least 6 months in duration, with some type of functional disability or decrease in quality of life. The signs and symptoms of GAD include a myriad of somatic symptoms including muscle tension, headaches, backaches, fatigue, restlessness, insomnia, as well as psychological feelings of worry, anxiety, and feeling overwhelmed. Both pharmacotherapy and psychotherapy are effective in decreasing the signs and symptoms of GAD. Unfortunately, the vast majority of patients with GAD never receive adequate pharmacotherapy or psychotherapy. Therefore, the development of a complementary and alternative therapy that has demonstrated efficacy for GAD might be well received by patients. This study's goals are to investigate the efficacy of Swedish massage therapy vs. light touch therapy and better understand the biological effects of massage in patients with anxiety. Qualified participants will be randomly assigned to one of two groups in which they will receive Swedish massage therapy twice per week for 12 weeks or Light Touch therapy twice per week for 6 weeks followed by Swedish massage therapy twice per week for the next 6 weeks. The total length of the study is 13 weeks, which includes a screening visit that takes about 3 hours and two therapy visits per week for 12 weeks that last about 1 hour each. Blood and urine will be collected at three of the visits. Compensation is up to $400 for completing the entire study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 15, 2011
CompletedFirst Posted
Study publicly available on registry
April 19, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedJuly 27, 2017
July 1, 2017
3.3 years
April 15, 2011
July 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hamilton Anxiety Scale
25 times over an average of 13 weeks
Study Arms (2)
Swedish Massage
EXPERIMENTALLight Touch
SHAM COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Age 18 to 65 years old
- Able to read and understand English
- Medically healthy as demonstrated by a normal history and physical examination
- Meet criteria for a primary diagnosis of current GAD as demonstrated by a structured clinical interview for DSM-IV (SCID),
- HAM-A score of greater than 14
- Normal blood work and urinalysis (CBC, Renal, Hepatic, Tox Screen)
You may not qualify if:
- Individuals who lack a capacity to consent, or whose capacity to provide consent is questionable to the investigator
- Current suicidal ideation (core of 3 or more on the HAM-D suicide item)
- Current diagnosis of schizophrenia
- Current diagnosis of bipolar disorder
- Current diagnosis of borderline personality disorder
- Comorbid secondary disorder diagnosis of OCD
- Current illicit drug use
- Excessive regular use of alcohol (more than two 5-oz glasses of wine or equivalents/day) or a history of binge drinking (more than 7 drinks/24 hour period) within the last six months
- Regular or "PRN" psychotropic medication use
- Current participation in psychotherapy or cognitive behavioral therapy
- Pregnancy
- Shift work schedule
- Active dieting for weight loss
- Active medical problems
- Fibromyalgia (on daily medication)
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emory University, Department of Psychiatry
Atlanta, Georgia, 30322, United States
Related Publications (1)
Rapaport MH, Schettler P, Larson ER, Edwards SA, Dunlop BW, Rakofsky JJ, Kinkead B. Acute Swedish Massage Monotherapy Successfully Remediates Symptoms of Generalized Anxiety Disorder: A Proof-of-Concept, Randomized Controlled Study. J Clin Psychiatry. 2016 Jul;77(7):e883-91. doi: 10.4088/JCP.15m10151.
PMID: 27464321DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark H Rapaport, M.D.
Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chair
Study Record Dates
First Submitted
April 15, 2011
First Posted
April 19, 2011
Study Start
September 1, 2010
Primary Completion
January 1, 2014
Study Completion
July 1, 2014
Last Updated
July 27, 2017
Record last verified: 2017-07